← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sinopia Biosciences, Inc.
San Diego, CA
$15,103,899
Total funding
15
Grants
Funding over time
peak $3.1M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,103,899 · 15
By mechanism
R44$12,569,089 · 6
R43$2,534,810 · 9
Investigators at Sinopia Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Preclinical assessment of a novel compound for treating radiation-induced oral mucositis$1,493,635
R44 · FY2024 · DE
Preclinical development of a novel therapeutic for Parkinson's disease$1,461,860
R44 · FY2023 · NS
Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery$1,335,997
R44 · FY2021 · GM
Preclinical development of a novel therapeutic for Parkinson's disease$1,282,299
R44 · FY2024 · NS
Improving safety and efficacy of platelet transfusion through systems biology$1,099,022
R44 · FY2017 · HL
Improving red blood cell transfusion through systems biology$1,029,290
R44 · FY2016 · HL
Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery$871,587
R44 · FY2022 · GM
Preclinical assessment of a novel compound for treating radiation-induced oral mucositis$849,193
R44 · FY2025 · DE
Developing a systems biology platform for predicting, preventing, and treating drug side effects$802,538
R44 · FY2019 · GM
Developing a systems biology platform for predicting, preventing, and treating drug side effects$754,478
R44 · FY2020 · GM
Preclinical development of a novel therapeutic for Parkinson's disease$577,562
R44 · FY2021 · NS
Improving red blood cell transfusion through systems biology$443,351
R44 · FY2017 · HL
Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery$442,427
R43 · FY2018 · GM
Improving safety and efficacy of platelet transfusion through systems biology$428,727
R44 · FY2018 · HL
Development and validation of data standards and computational methods for large scale metabolomics data analysis for data driven drug discovery$350,000
R43 · FY2024 · GM
Development of neural network models to enable efficient metabolomic characterization of compound libraries for data-driven drug discovery$350,000
R43 · FY2025 · GM
Preclinical assessment of a novel compound for treating radiation-induced oral mucositis$318,284
R43 · FY2022 · DE
Development of a metabolomics enabled AI/ML platform for discovery of new treatments to enhance drug sensitivity in cancer$285,599
R43 · FY2025 · CA
Improving safety and efficacy of platelet pathogen inactivation techniques through systems biology$224,284
R43 · FY2019 · HL
Improving safety and efficacy of platelet transfusion through systems biology$223,582
R43 · FY2015 · HL